1. Cainap C, Qin S, Huang WT, Chung IJ, Pan H, Cheng Y, Kudo M, Kang YK, Chen PJ, Toh HC, Gorbunova V, Eskens FA, Qian J, McKee MD, Ricker JL, Carlson DM, El-Nowiem S. Linifanib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: Results of a Randomized Phase III Trial. J Clin Oncol. 2015 Jan 10;33(2):172-9. Epub 2014 Dec 8.
  2. Chan HL, Ahn SH, Chang TT, Peng CY, Wong D, Coffin CS, Lim SG, Chen PJ, Janssen H, Marcellin P, Serfaty L, Zeuzem S, Cohen D, Critelli L, Xu D, Wind-Rotolo M, Cooney E; LIRA-B Study Team. Peginterferon Lambda for the Treatment of HBeAg-Positive Chronic Hepatitis B: A Randomized Phase 2b Study (LIRA-B). J Hepatol. 2015 Dec 28. pii: S0168-8278(15)00859-4.
  3. Chang PF, Lin YC, Liu K, Yeh SJ, Ni YH. Heme oxygenase-1 gene promoter polymorphism and the risk of pediatric nonalcoholic fatty liver disease. Int J Obesity 2015; 39(8):1236-40.
  4. Chen CL, Yang JY, Lin SF, Sun CA, Bai CH, You SL, Chen CJ, Kao JH, Chen PJ, Chen DS. Slow decline of hepatitis B burden in general population: Results from a population-based survey and longitudinal follow-up study in Taiwan. J Hepatol. 2015 Aug;63(2):354-63.
  5. Chen GY, Su TH, Kao JH. Successful treatment of chronic hepatitis B and D with pegylated-interferon plus entecavir. J Formos Med Assoc. 2015 Nov;114(11):1140-1.
  6. Chen HL, Lee CN, Chang CH, Ni YH, Shyu MK, Chen SM, Hu JJ, Lin HH, Zhao LL, Mu SC, Lai MW, Lee CL, Lin HM, Tsai MS, Hsu JJ, Chen DS, Arnold Chan K, Chang MH; Taiwan Study Group for the Prevention of Mother-to-Infant Transmission of HBV (PreMIT study). Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus. Hepatology 2015; 62(2):375-86.
  7. Chen TP, Hung HF, Chen MK, Lai HH, Hsu WF, Huang KC, Yang KC. Helicobacter Pylori Infection is Positively Associated with Metabolic Syndrome in Taiwanese Adults: a Cross-Sectional Study. Helicobacter. 2015 Jun;20(3):184-91.
  8. Cheng HR, Kao JH, Wu HL, Tseng TC, Liu CH, Yang HC, Su TH, Chen PJ, Chen DS, Liu CJ. Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection. Hepatol Int. 2015 Jan;9(1):35-42.
  9. Hsu CS, Liu WL, Chao YC, Lin HH, Tseng TC, Wang CC, Chen DS, Kao JH. Adipocytokines and liver fibrosis stages in patients with chronic hepatitis B virus infection. Hepatol Int. 2015 Apr;9(2):231-42.
  10. Cheng HR, Kao JH, Wu HL, Tseng TC, Liu CH, Yang HC, Su TH, Chen PJ, Chen DS, Liu CJ. Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection. Hepatol Int. 2015;9:35-42.
  11. Cheng SY, Huang KC. New aspects of travel medicine in Taiwan. Formosan J Med. 2015; 19:247-54
  12. Cheng-Maw Ho, Ya-Hui Chen, Chin-Sung Chien, Yi-Tian Ho, Shu-Li Ho, Rey-Heng Hu, Po-Huang Lee, Hui-Ling Chen. Transplantation Speed Offers Early Hepatocyte Engraftment in Acute Liver Injured Rats – A Translational Study with Clinical Implication. Liver Transplantation 2015. 21(5):652-661.
  13. Cheng-Maw Ho, Young-Jen Lin, Shu-Li Ho, Hui-Ling Chen. Ductular reaction in acute liver failure. Liver International 2016. (in press) [4.850; 13/76]
  14. Chia-Hung Hung, Fuh-Yu Chang, Tien-Li Chang, Yu-Ting Chang , Kai-Wen Huang, Po-Chin Liang. Micromachining NiTi tubes for use in medical devices by using a femtosecond laser. Optics and Lasers in Engineering. 2015. March;66:34–40.
  15. Chiang CH, Huang KC. Reply to "diabetes, dyslipidemia and death from hepatocellular carcinoma in the middle-aged and elderly." Hepatology. 2014 Sep 10. doi: 10.1002/hep.27427. Hepatology. 2015 May;61(5):1763-4.
  16. Chiang JK, Chen CL, Tseng FY, Chi YC, Huang KC, Yang WS. Higher blood aldosterone level in metabolic syndrome is independently related to adiposity and fasting plasma glucose. Cardiovasc Diabetol. 2015 Jan 13;14(1):3.
  17. Chiu JY, Wu JF, Chen HL, Hsu HY, Chang MH, Ni YH. Correlation between gastroesophageal reflux disease questionnaire and erosive esophagitis in school-aged children receiving endoscopy. Pediatr Neonatol 2015; (in press)
  18. Chou HH, Chien WH, Wu LL, Cheng CH, Chung CH, Horng JH, Ni YH, Tseng HT, Wu D, Lu X, Wang HY, Chen PJ, Chen DS. Age-related immune clearance of hepatitis B virus infection requires the establishment of gut microbiota. Proc Natl Acad Sci U S A. 2015 Feb 17;112(7):2175-80..
  19. Chua HH, Tsuei DJ, Lee PH, Jeng YM, Lu J, Wu JF, Su DS, Chen YH, Chien CS, Kao PC, Lee CN, Hu RH, Ni YH, Chang MH. RBMY, a novel inhibitor of GSK3β, increases tumor stemness and predicts poor prognosis of hepatocellular Carcinoma. Hepatology 2015; 62 (5):1480-96.
  20. Chung CS, Chang PF, Liao CH, Lee TH, Chen Y, Lee YC, Wu MS, Wang HP, Ni YH*. Differences of microbiota in small bowel and feces between irritable bowel syndrome patients and healthy subjects. Scand J Gastroenterol 2016;
  21. Chyuan IT, Tsai HF, Tzeng HT, Sung CC, Wu CS, Chen PJ, Hsu PN. Tumor necrosis factor-alpha blockage therapy impairs hepatitis B viral clearance and enhances T-cell exhaustion in a mouse model. Cell Mol Immunol. 2015 May;12(3):317-25.
  22. Colvin RA, Tanwandee T, Piratvisuth T, Thongsawat S, Hui AJ, Zhang H, Hong R, Chen PJ, Chuang WL, Sobhonslidsuk A, Li R, Qi Y, Praestgaard J, Han Y, Xu J, Stein DS; ABF656A2206 study group. A randomized, controlled pharmacokinetic and pharmacodynamic evaluation of albinterferon in patients with chronic hepatitis B infection. J Gastroenterol Hepatol. 2015 Jan;30(1): 184-91.
  23. Hsu CS, Chao YC, Lin HH, Chen DS, Kao JH. Systematic Review: Impact of Interferon-based Therapy on HCV-related Hepatocellular Carcinoma. Sci Rep. 2015 May 12;5:9954.
  24. Hsu HY, Chang MH, Ni YH, Chiang CL, Wu JF, Chen HL. Universal infant immunization and occult hepatitis B virus infection in children and adolescents: a population-based study. Hepatology, 61(4):1183-91.
  25. Hu KC, Wang HY, Liu SC, Liu CC, Hung CL, Bair MJ, Liu CJ, Wu MS, Shih SC. Nonalcoholic fatty liver disease: Updates in noninvasive diagnosis and correlation with cardiovascular disease. World J Gastroenterol (in press)
  26. Huang CY1, Huang HL, Yang KC, Lee LT, Yang WS, Huang KC, Tseng FY. Serum Triglyceride Levels Independently Contribute to the Estimation of Visceral Fat Amount Among Nondiabetic Obese Adults. Medicine. 2015 Jun;94(23):e965.
  27. Huang MT, Liu WL, Lu CW, Huang JJ, Chuang HL, Huang YT, Horng JH, Liu P, Han DS, Chiang BL, Shih C, Chen PJ, Chen DS. Feedback regulation of IFN-α/β signaling by Axl receptor tyrosine kinase modulates HBV immunity. Eur J Immunol. 2015 Jun;45(6):1696-705. Epub 2015 May 15.
  28. Huang YW, Takahashi S, Tsuge M, Chen CL, Wang TC, Abe H, Hu JT, Chen DS, Yang SS, Chayama K, Kao JH. On-treatment low serum HBV RNA level predicts initial virological response in chronic hepatitis B patients receiving nucleoside analogue therapy. Antivir Ther. 2015;20(4):369-75.
  29. Huang YW, Wang TC, Yang SS, Lin SY, Fu SC, Hu JT, Liu CJ, Kao JH, Chen DS. Increased risk of hepatocellular carcinoma in chronic hepatitis C patients with new onset diabetes: a nation-wide cohort study. Aliment Pharmacol Ther. 2015 Oct;42(7):902-11.
  30. Huang YW, Yang SS, Kao JH. Reply to: Modulation of Toll-like receptor 9 expression on monocytes of viral hepatitis patients. Antivir Ther. 2015;20(6):669-70.
  31. Yang SS, Kao JH. Asunaprevir-containing regimens for the treatment of hepatitis C virus infection. Expert Rev Gastroenterol Hepatol. 2015 Jan;9(1):9-20.
  32. Hung YC, Lin CL, Liu CJ, Hung H, Lin SM, Lee SD, Chen PJ, Chuang SC, Yu MW. Development of risk scoring system for stratifying population for hepatocellular-carcinoma screening. Hepatology. 2015 Jun;61(6):1934-44. Epub 2015 Apr 13.
  33. Kai-Wen Huang, Jen-Jie Chieh*, Jin-Cheng Shi, Ming-Hsien Chiang. Assaying Carcinoembryonic Antigens by Normalized Saturation Magnetization. Nanoscale Research Letters. 2015. JUL; 10:277
  34. Kao JH. Hepatitis C virus infection in Taiwan: Past, present, and future. J Formos Med Assoc. 2015 Jul 27. pii: S0929-6646(15)00235-1.
  35. Kuo WT, Lee TC, Yang HY, Chen CY, Au YC, Lu YZ, Wu LL, Wei SC, Ni YH, Lin BR, Chen Y, Tsai YH, Kung JT, Sheu F, Lin LW, Yu LC. LPS receptor subunits have antagonistic roles in epithelial apoptosis and colonic carcinogenesis. Cell Death Differ. 2015; 22(10): 1590-604.
  36. Li CL, Yeh KH, Liu WH, Chen CL, Chen DS, Chen PJ, Yeh SH. Elevated p53 promotes the processing of miR-18a to decrease estrogen receptor-α in female hepatocellular carcinoma. Int J Cancer. 2015 Feb 15;136(4):761-70.
  37. Liang CC, Liu CH, Chung CS, Lin CK, Su TH, Yang HC, Liu CJ, Chen PJ, Chen DS, Kao JH. Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapy. J Infect Dis. 2015 May 1;211(9):1429-36..
  38. Lien TH, Bu LN, Wu JF, Chen HL, Chen AC, Lai MW, Shih HH, Lee IH, Hsu HY, Ni YH, Chang MH. Use of Lactobacillus casei rhamnosus to prevent cholangitis in biliary atresia after Kasai operation: a randomized study. J Pediatr Gastroenterol Nutr 2015; 60(5):654-8.
  39. Lin CL, Kao JH. Can noninvasive biomarkers replace liver biopsy for chronic hepatitis B? Hepatology. 2015 Apr 24. doi: 10.1002/hep.27865.
  40. Lin CL, Kao JH. Hepatitis B virus genotypes and variants. Cold Spring Harb Perspect Med. 2015 May 1;5(5):a021436.
  41. Lin CL, Kao JH. Perspectives and control of hepatitis B virus infection in Taiwan. J Formos Med Assoc. 2015 Oct;114(10):901-9.
  42. Lin CL, Liu CH, Wang CC, Liang CC, Su TH, Liu CJ, Kao JH. Serum Biomarkers Predictive of Significant Fibrosis and Cirrhosis in Chronic Hepatitis B. J Clin Gastroenterol. 2015 Sep;49(8):705-13.
  43. Lin CL, Tseng TC, Kao JH. What can we learn from hepatitis B virus clinical cohorts? Liver Int. 2015;35 Suppl 1:91-9.
  44. Lin PH, Kuo WH, Huang AC, Lu YS, Lin CH, Kuo SH, Wang MY, Li HY, Yang YH, Hsu YH, Fan SC, Li LY, Yu SL, Chang KJ, Chen PL, Ni YH, Huang CS.Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer. Oncotarget 2016; (in press)
  45. Lin YC, Huang DY, Wang JS, Lin YL, Hsieh SL, Huang KC, Lin WW. Syk is involved in NLRP3 inflammasome-mediated caspase-1 activation through adaptor ASC phosphorylation and enhanced oligomerization. J Leukoc Biol. J Leukocyte Biol 2015 Jan 20. pii: jlb.3HI0814-371RR.
  46. Lin YY, Liu C, Chien WH, Wu LL, Tao Y, Wu D, Lu X, Hsieh CH, Chen PJ, Wang HY, Kao JH, Chen DS. New insights into the evolutionary rate of hepatitis B virus at different biological scales. J Virol. 2015 Apr;89(7):3512-22.
  47. Liu CH, Huang CF, Liu CJ, Dai CY, Huang JF, Lin JW, Liang CC, Yang SS, Lin CL, Su TH, Yang HC, Chen PJ, Chen DS, Chuang WL, Kao JH, Yu ML. Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naïve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial. Sci Rep. 2015 Oct 15;5:15255.
  48. Liu CH, Huang CF, Liu CJ, Dai CY, Huang JF, Lin JW, Liang CC, Yang SS, Lin CL, Su TH, Yang HC, Chen PJ, Chen DS, Chuang WL, Kao JH, Yu ML. Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trial. Sci Rep. 2015;5:11710.
  49. Liu CH, Kao JH. Nanomedicines in the treatment of hepatitis C virus infection in Asian patients: optimizing use of peginterferon alfa. Int J Nanomedicine. 2014;9:2051-67.
  50. Liu CH, Liang CC, Liu CJ, Lin CL, Su TH, Yang HC, Chen PJ, Chen DS, Kao JH. Comparison of Abbott RealTime HCV Genotype II with Versant line probe assay 2.0 for hepatitis C virus genotyping. J Clin Microbiol. 2015 May;53(5):1754-7.
  51. Liu CH, Liu CJ, Huang CF, Lin JW, Dai CY, Liang CC, Huang JF, Hung PH, Tsai HB, Tsai MK, Lee CY, Chen SI, Yang SS, Su TH, Yang HC, Chen PJ, Chen DS, Chuang WL, Yu ML, Kao JH. Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: a randomised trial. Gut. 2015 Feb;64(2):303-11.
  52. Liu CH, Sheng WH, Sun HY, Hsieh SM, Lo YC, Liu CJ, Su TH, Yang HC, Liu WC, Chen PJ, Chen DS, Hung CC, Kao JH. Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naïve Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study. Sci Rep. 2015 Nov 30;5:17410.
  53. Liu CJ, Chen PJ, Chen DS, Tseng TC, Kao JH. Perspectives on dual hepatitis B and C infection in Taiwan. J Formos Med Assoc. 2015 Jul 15. pii: S0929-6646(15)00228-4.
  54. Liu CJ, Chen TC, Chen PJ, Wang H, Tseng TC, Cheng HR, Liu CH, Chen DS, Kao JH. Microevolution of the hepatitis B virus genome in hepatitis B e-antigen-positive carriers: Comparison of genotypes B and C at various immune stages. J Gastroenterol Hepatol 2015;30:172-177.
  55. Liu CY, Chen KF, Chen PJ. Treatment of Liver Cancer. Cold Spring Harb Perspect Med. 2015 Jul 17;5(9). pii: a021535.
  56. Liu J, Tseng TC, Yang HI, Lee MH, Batrla-Utermann R, Jen CL, Lu SN, Wang LY, You SL, Chen PJ, Chen CJ, Kao JH. Predicting Hepatitis B Virus (HBV) Surface Antigen Seroclearance in HBV e Antigen-Negative Patients With Chronic Hepatitis B: External Validation of a Scoring System. J Infect Dis. 2015;15;211(10):1566-73.
  57. Liu J, Tseng TC, Yang HI, Lee MH, Batrla-Utermann R, Jen CL, Lu SN, Wang LY, You SL, Chen PJ, Chen CJ, Kao JH. Predicting HBsAg Seroclearance in HBeAg-negative Chronic Hepatitis B Patients: External Validation of a Scoring System. J Infect Dis. 2015 May 15;211(10):1566-73.
  58. Liu YL, Lu CW, Shi L, Liou YM, Lee LT, Huang KC. Low intensive lifestyle modification in young adults with metabolic syndrome a community-based interventional study in Taiwan. Medicine. 2015 Jun;94(22):e916.
  59. Liu YW, Wu JF, Chen HL, Hsu HY, Chang MH, Hsu WC, Tseng PH, Wang HP, Ni YH*. The correlation between endoscopic reflux esophagitis and combined multichannel intraluminal impedance-pH monitoring in children. Pediatr Neonatol 2015; (in press)
  60. P.-C. Liang, H.-S. Lai, T.T.-F. Shih, C.-H. Wu, K.-W. Huang. Initial institutional experience of uncooled single-antenna microwave ablation for large hepatocellular carcinoma. Clinical Radiology. 2015. May;70(5):e35-40.
  61. Park JW, Chen M, Colombo M, Roberts LR, Schwartz M, Chen PJ, Kudo M, Johnson P, Wagner S, Orsini LS, Sherman M. Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study. Liver Int. 2015 Sep;35(9):2155-66..
  62. Peng CY, Hsieh TC, Hsieh TY, Tseng KC, Lin CL, Su TH, Tseng TC, Lin HH, Wang CC, Kao JH. HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients. J Formos Med Assoc. 2015 Apr;114(4):308-13.
  63. Sarin SK, Kumar M, Lau GK, Abbas Z, Chan HL, Chen CJ, Chen DS, Chen HL, Chen PJ, Chien RN, Dokmeci AK, Gane E, Hou JL, Jafri W, Jia J, Kim JH, Lai CL, Lee HC, Lim SG, Liu CJ, Locarnini S, Al Mahtab M, Mohamed R, Omata M, Park J, Piratvisuth T, Sharma BC, Sollano J, Wang FS, Wei L, Yuen MF, Zheng SS, Kao JH. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int 2015 Nov 13.
  64. Shu-Hsien Liao, Jen-Jie Chieh, Yen-Ting Chou, Ming-Wei Wang, Hsin-Hsien Chen, Kai-Wen Huang, Hong-Chang Yang, Herng-Er Horng. Signal Analysis and Liver Tumor Discrimination by Using a High-Tc SQUID-Based Low-Field NMR System in Hospital. IEEE TRANSACTIONS ON APPLIED SUPERCONDUCTIVITY. 2015. JUNE; 25(3): 1602404
  65. Song LW, Liu PG, Liu CJ, Zhang TY, Cheng XD, Wu HL, Yang HC, Hao XK, Yuan Q, Zhang J, Kao JH, Chen DS, Chen PJ, Xia NS. Quantitative hepatitis B core antibody levels in the natural history of hepatitis B virus infection. Clin Microbiol Infect. 2015 Feb;21(2):197-203.
  66. Song LW, Liu PG, Liu CJ, Zhang TY, Cheng XD, Wu HL, Yang HC, Hao XK, Yuan Q*, Zhang J, Kao JH, Chen DS, Chen PJ, Xia NS. Quantitative hepatitis B core antibody levels in the natural history of hepatitis B virus infection. Clin Microbiol Infect. 2015 Feb;21(2):197-203..
  67. Song LW, Liu PG, Liu CJ, Zhang TY, Cheng XD, Wu HL, Yang HC, Hao XK, Yuan Q, Zhang J, Kao JH, Chen DS, Chen PJ, Xia NS. Quantitative hepatitis B core antibody levels in the natural history of hepatitis B virus infection. Clin Microbiol Infect 2015;21:197-203.
  68. Song LW, Wang YB, Fang LL, Wu Y, Yang L, Chen JY, Ge SX, Zhang J, Xiong YZ, Deng XM, Min XP, Zhang J, Chen PJ, Yuan Q, Xia NS. Rapid fluorescent lateral-flow immunoassay for hepatitis B virus genotyping. Anal Chem. 2015 May 19;87(10):5173-80.
  69. Su TH, Kao JH. Improving clinical outcomes of chronic hepatitis B virus infection. Expert Rev Gastroenterol Hepatol. 2015 Feb;9(2):141-54.
  70. Su TH, Liu CJ, Shu PY, Fu YH, Chang CH, Jao P, Kao JH. Associated factors and clinical implications of serum aminotransferase elevation in scrub typhus. J Microbiol Immunol Infect. 2014;S1684-1182(14)00232-1.
  71. Su TH, Liu CJ, Shu PY, Fu YH, Chang CH, Jao P, Kao JH. Associated factors and clinical implications of serum aminotransferase elevation in scrub typhus. J Microbiol Immunol Infect 2014 Nov 11. pii: S1684-1182(14)00232-1. doi: 10.1016/j.jmii.2014.10.005.
  72. Su TH, Liu CJ, Tseng TC, Chou SW, Liu CH, Yang HC, Wu SJ, Chen PJ, Chen DS, Chen CL, Kao JH. Hepatitis C virus infection increases the risk of lymphoid-neoplasms: A population-based cohort study. Hepatology. 2015 Dec 10. doi: 10.1002/hep.28387.
  73. Su TH, Shiau CW, Jao P, Liu CH, Liu CJ, Tai WT, Jeng YM, Yang HC, Tseng TC, Huang HP, Cheng HR, Chen PJ, Chen KF, Kao JH, Chen DS. Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition. Proc Natl Acad Sci USA. 2015 Jun 9;112(23):7243-8.
  74. Tsai JS, Chen SC, Huang KC, Lue BH, Lee LT, Chiu TY, Chen CY, Guo FR, Chuang LM. Plasma zinc α2-glycoprotein levels are elevated in smokers and correlated with metabolic syndrome. Eur J Clin Invest. 2015 Feb 24. doi: 10.1111/eci.12425.
  75. Tseng FY, Lin WY, Li CI, Li TC, Lin CC, Huang KC. Subclinical hypothyroidism is associated with increased risk for cancer mortality in adult Taiwanese-a 10 years population-based cohort. PLoS One. 2015 Apr 1;10(4):e0122955.
  76. Tseng KC, Tseng CW, Hsieh TY, Peng CY, Lin CL, Su TH, Tseng TC, Lin HH, Wang CC, Kao JH. Efficacy of entecavir therapy for hepatitis B e-antigen positive chronic hepatitis B patients with prior exposure to interferon or nucleoside/nucleotide analogues. Hepatol Res. 2015 Sep 30. doi: 10.1111/hepr.12600.
  77. Tseng TC, Kao JH. Treating Immune-tolerant Hepatitis B. J Viral Hepat. 2015 Feb;22(2):77-84.
  78. Tseng TC, Liu CJ, Chen CL, Yang WT, Yang HC, Su TH, Wang CC, Kuo SF, Liu CH, Chen PJ, Chen DS, Kao JH. Higher lifetime chance of spontaneous surface antigen loss in hepatitis B carriers with genotype C infection. Aliment Pharmacol Ther. 2015 May;41(10):949-60.
  79. Tseng TC, Liu CJ, Yang HC, Chen CL, Yang WT, Tsai CS, Kuo SF, Verbree FC, Su TH, Wang CC, Liu CH, Chen PJ, Chen DS, Kao JH. Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers. Gut. 2015 Feb;64(2):292-302.
  80. Wang CC, Lin CL, Hsieh TY, Tseng KC, Peng CY, Su TH, Yang SS, Hsu YC, Chen TM, Kao JH. Efficacy and resistance to telbivudine treatment in chronic hepatitis B patients with favorable predictors: a multicenter study in Taiwan. Hepatol Int. 2015 Sep 23.
  81. Wang CC, Liu CH, Lin CL, Wang PC, Tseng TC, Lin HH, Kao JH. Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients. J Formos Med Assoc. 2015 Oct;114(10):923-8.
  82. Wang CC, Tseng TC, Kao JH. Hepatitis B virus infection and metabolic syndrome: fact or fiction? J Gastroenterol Hepatol. 2015 Jan;30(1):14-20.
  83. Wang SH, Chen PJ, Yeh SH. Gender Disparity in Chronic Hepatitis B: Mechanisms of Sex Hormones. J Gastroenterol Hepatol. 2015 Aug;30(8):1237-45.
  84. Wang SH, Yeh SH, Shiau CW, Chen KF, Lin WH, Tsai TF, Teng YC, Chen DS, Chen PJ. Sorafenib Action in Hepatitis B Virus X-Activated Oncogenic Androgen Pathway in Liver through SHP-1. J Natl Cancer Inst. 2015 Jul 23;107(10). pii: djv190. Print 2015 Oct.
  85. Wu CC, Tsai CH, Lu YC, Lin HC, Hwang JH, Lin YH, Yang WS, Chen PJ, Liao WC, Lee YL, Liu TC, Hsu CJ. Contribution of adiponectin and its type 1 receptor to age-related hearing impairment. Neurobiol Aging. 2015 Jun;36(6):2085-93.
  86. Wu FY, Liao YW, Wu JF, Chen HL, Hsu HY, Chang MH, Ni YH (2015, Oct). A Simple and Rapid Test-card Method to Detect Hepatitis B Surface Antigen and Antibody: Potential Application in Young Children and Infants. Pediatrics and Neonatology, [Epub ahead of print].
  87. Wu JF, Chiu YC, Chang KC, Chen HL, Ni YH, Hsu HY, Chang MH. Predictors of hepatitis B e antigen-negative hepatitis in chronic hepatitis B virus infected patients from childhood to adulthood. Hepatology 2015; (in press)
  88. Wu JF, Hsu HY, Chiu YC, Chen HL, Ni YH, Chang MH. The effects of cytokines on spontaneous hepatitis B surface antigen seroconversion in chronic hepatitis B virus infection. J Immunol 2015; 194(2):690-6.
  89. Ya-Hui Chen, Hui-Ling Chen, Chin-Sung Chien, Shang-Hsin Wu, Yi-Tian Ho, Chun-Hsien Yu, Mei-Hwei Chang. Contribution of Mature Hepatocytes to Biliary Regeneration in Rats with Acute and Chronic Biliary Injury. PLoS One. 2015. 10(8):e0134327. [3.234; 8/56]
  90. Yang CC, Tsai WL, Su WW, Huang CF, Cheng PN, Lo CC, Tseng KC, Mo LR, Wang CH, Hsu SJ, Lai HC, Su CW, Liu CJ, Peng CY, Yu ML. Rapid Prediction of Treatment Futility of Boceprevir with Peginterferon-Ribavirin for Taiwanese Treatment Experienced Hepatitis C Virus Genotype 1-Infected Patients. PLoS One 2015 Sep 14;10(9):e0137852.
  91. Yang HC, Kao JH. Viral hepatitis. HBV cure--can we pin our hopes on immunotherapy? Nat Rev Gastroenterol Hepatol. 2015 Mar;12(3):129-31.
  92. Yang HI, Tseng TC, Liu J, Lee MH, Liu CJ, Su TH, Batrla-Utermann R, Chan HL, Kao JH, Chen CJ.